Status:
COMPLETED
Coronary Bifurcation Stenting (COBIS) Registry in South Korea
Lead Sponsor:
Samsung Medical Center
Conditions:
Coronary Bifurcation Lesion
Eligibility:
All Genders
18+ years
Brief Summary
The COBIS registry is multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. The aim of the study was to find out the current status of bifurcation...
Eligibility Criteria
Inclusion
- Age \>= 18 years
- Any type of de novo bifurcation lesion with a parent vessel \>= 2.5 mm and side branch\>= 2.0 mm by visual estimation
- Treated with drug-eluting stent
Exclusion
- Cardiogenic Shock
- ST elevation MI within 48hours
- Expected survival less than 1 year
- Left main bifurcation
- Allergy to the antiplatelets
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
1919 Patients enrolled
Trial Details
Trial ID
NCT00851526
Start Date
January 1 2004
End Date
December 1 2008
Last Update
July 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710